Co-Diagnostics Inc (CODX)

Currency in USD
0.261
-0.017(-6.13%)
Closed·
After Hours
0.263+0.002(+0.81%)
·

CODX Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.24 / -0.34
Revenue / Forecast
50.00K / 400.00K
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.66--/200K----Free Sign Up
03/2025-0.24/-0.3450K/400K+29.41%-87.5%Free Sign Up
12/2024-0.36/-0.33149.33K/375K-9.09%-60.18%Free Sign Up
09/2024-0.32/-0.33641.14K/375K+3.03%+70.97%Free Sign Up
06/2024-0.25/-0.342.66M/375K+26.47%+609.33%Free Sign Up
03/2024-0.31/-0.21500K/3.1M-47.62%-83.87%Free Sign Up
12/2023-1.2/-0.26.8M/2.5M-500%+172%Free Sign Up
09/2023-0.2/-0.292.5K/200K+31.03%-98.75%Free Sign Up
06/2023-0.31/-0.24200K/500K-29.17%-60%Free Sign Up
03/2023-0.2/-0.24610K/1.2M+16.67%-49.17%Free Sign Up

All numbers in USD

Co-Diagnostics Inc Earnings Call Summary for Q1/2025

  • Q1 2025 net loss improved to $0.24/share from $0.31/share YoY, despite revenue drop to $100,000 from $500,000; stock up 4.14% after-hours
  • Company maintains strong liquidity with 4.41 current ratio; plans clinical trials for diagnostic tests in 2025, aiming for FDA approval of COVID-19 test
  • Strategic expansion in India with new manufacturing facility targeted for completion by year-end to strengthen presence in emerging markets
  • CEO highlights potential of Kodiak PCR platform; CFO emphasizes capital securing strategy through equity financing and grants for growth initiatives
  • Analysts focused on COVID-19 test submission timing and clinical trial schedules for TB, HPV, and respiratory panel tests during Q&A session
Last Updated: 08/05/2025, 23:06
Read Full Transcript

FAQ

What Is Co-Diagnostics's Earnings Per Share (TTM)?

The Co-Diagnostics EPS (TTM) is -1.16.

When Is The Next Co-Diagnostics Earnings Date?

Co-Diagnostics will release its next earnings report on 06 Aug 2025.

What Is Co-Diagnostics’s Revenue Forecasts For Upcoming Quarters?

Co-Diagnostics’s revenue forecast is 200.00K.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.